TRANSLATIONAL GENOMICS RESEARCH INSTITUTE, BARROW NEUROLOGICAL INSTITUTE, AND NEUMOCORE, INC. COLLABORATING TO TEST FDA APPROVED DRUGS KNOWN TO PASS THE BLOOD BRAIN BARRIER FOR EFFICACY AND ACCELERATED USE IN GBM PATIENTS.